NCT05781009View on ClinicalTrials.gov

Pregnenolone for the Treatment of Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Alcohol Use Disorder
Interventions
DRUG

Pregnenolone

300mg

DRUG

Placebo

placebo

Trial Locations (1)

06519

RECRUITING

The Yale Stress Center: Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER